References

1. Goldenberg SG, Alex M, Joshi RA, et al. Nonatheromatous peripheral vascular disease of the lower extremity in diabetes mellitus. Diabetes 1959;8:261-273.

2. LoGerfo FW, Coffman JD. Current concepts. Vascular and microvascular disease of the foot in diabetes. Implications for foot care. N Engl J Med 1984;311:1615-1619.

3. Strandness DE, Priest RE, Gibbons GE. Combined clinical and pathologic study of diabetic and nondiabetic peripheral arterial disease. Diabetes 1964;13:366-372.

4. Conrad MC. Large and small artery occlusion in diabetics and nondiabetics with severe vascular disease. Circulation 1967;36:83-91.

5. Parving HH, Viberti GC, Keen H, Christiansen JS, Lassen NA. Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism 1983;32:943-949.

6. Flynn MD, Tooke JE. Aetiology of diabetic foot ulceration: A role for the microcirculation? Diab Med 1992;8:320-329.

7. Morgensen CE, Schmitz A, Christensen CR. Comparative renal pathophysiology relevant to IDDM and NIDDM patients. Diab Metab Rev 1988;4:453-483.

8. Cunha-Vaz JG. Studies on the pathophysiology of diabetic retinopathy. The blood-retinal barrier in diabetes. Diabetes 1983;32:20-27.

9. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.

10. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-853.

11. Stevens MJ, Feldman EL, Green DA. The aetiology of diabetic neuropathy: the combined roles of metabolic and vascular defects. Diab Med 1995;12:566-579.

12. Feldman EL, Stevens MJ, Green DA. Pathogenesis of diabetic neuropathy. Clin Neurosci 1997;4:365-370.

13. Malik RA, Tesfaye S, Thompson SD, et al. Transperineurial capillary abnormalities in the sural nerve of patients with diabetic neuropathy. Microvasc Res 1994;48:236-245.

14. Tooke JE. Possible pathophysiological mechanisms for diabetic angiopathy in type 2 diabetes. J Diab Compl 2000;14:197-200.

15. Stevens MJ. Nitric oxide as a potential bridge between the metabolic and vascular hypotheses of diabetic neuropathy. Diab Med 1995;12:292-295.

16. Morris SJ, Shore AC, Tooke JE. responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM. Diabetologia 1995;38:1337-1344.

17. Cameron NE, Eaton SE, Cotter MA, Tesfaye S. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 2001;44:1973-1988.

18. Veves A, Akbari CM, Primavera J, et al. Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes 1998;47:457-463.

19. Jude EB, Boulton AJ, Ferguson MW, Appleton I. The role of nitric oxide synthase isoforms and arginase in the pathogenesis of diabetic foot ulcers: possible modulatory effects by transforming growth beta 1. Diabetologia 1999;42:748-757.

20. Monti LD, Barlassina C, Citterio L, et al. Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. Diabetes 2003;52: 1270-1275.

21. Noiri E, Satoh H, Taguchi J, et al. Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension 2002;40:535-540.

22. Szabo C, Zanchi A, Komjati K, et al. Poly(ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation 2002;106:2680-2686.

23. Arora S, Smakowski P, Frykberg RG, et al. Differences in foot and forearm skin microcirculation in diabetic patients with and without neuropathy. Diabetes Care 1998;21:1339-1344.

24. Tesfaye S, Harris N, Jakubowski J, et al. Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography. Diabetologia 1993;36:1266-1274.

25. Flynn MD, Tooke JE. Diabetic neuropathy and the microcirculation. Diab Med 1995;12: 298-301.

26. Lefrandt JD, Bosma E, Oomen PH, et al. Sympathetic mediated vasomotion and skin capillary permeability in diabetic patients with peripheral neuropathy. Diabetologia 2003;46:40-47.

27. Eaton RP, Qualls C, Bicknell J, Sibbitt WL, King MK, Griffey RH. Structure-function relationships within peripheral nerves in diabetic neuropathy: the hydration hypothesis. Diabetologia 1996;39:439-446.

28. Lewis T. The blood vessels of the human skin and their responses. Shaw and Sons, London, 1927.

29. Hamdy O, Abou-Elenin K, LoGerfo FW, Horton ES, Veves A. Contribution of nerve-axon reflex-related vasodilation to the total skin vasodilation in diabetic patients with and without neuropathy. Diabetes Care 2001;24:344-349.

30. Caselli A, Rich J, Hanane T, Uccioli L, Veves A. Role of C-nociceptive fibers in the nerve axon reflex-related vasodilation in diabetes. Neurology 2003;60:297-300.

31. Caselli A, Spallone V, Marfia G, Battista C, Veves A, Uccioli L. Validation of the nerve axon reflex for the assessment of small nerve fibers' dysfunction. Diabetologia 2004; 47:A34.

32. Calcutt NA, Chen P, Hua XY. Effects of diabetes on tissue content and evoked release of calcitonin gene-related peptide-like immunoreactivity from rat sensory nerves. Neurosci Lett 1998;254:129-132.

33. Yorek MA, Coppey LJ, Gellett JS, Davidson EP. Sensory nerve innervation of epineurial arterioles of the sciatic nerve containing calcitonin gene-related peptide: effect of streptozotocin-induced diabetes. Exp Diabesity Res 2004;5:187-193.

34. Arora S, Pomposelli F, LoGerfo FW, Veves A. Cutaneous microcirculation in the neuropathic diabetic foot improves significantly but not completely after successful lower extremity revascularization. J Vasc Surg 2002;35:501-505.

35. Malik RA, Newrick PG, Sharma AK, et al. Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia 1989;32:92-102.

36. Britland ST, Young RJ, Sharma AK, Clarke BF. Relationship of endoneurial capillary abnormalities to type and severity of diabetic polyneuropathy. Diabetes 1990;39:909-913.

37. Tooke JE, Ostergren J, Fagrell B. Synchronous assessment of human skin microcirculation by laser doppler flowmetry and dynamic capillaroscopy. Int J Microcirc Clin Exp 1983; 2:277-284.

38. Vinik AI, Erbas T, Park TS, Pierce KK, Stansberry KB. Methods for evaluation of peripheral neurovascular dysfunction. Diabete Technol Ther 2001;3:29-50.

39. Agewall S, Doughty RN, Bagg W, Whalley GA, Braatvedt G, Sharpe N. Comparison of ultrasound assessment of flow-mediated dilatation in the radial and brachial artery with upper and forearm cuff positions. Clin Physiol 2001;21(1):9-14.

40. Gaenzer H, Neumayr G, Marschang P, Sturm W, Kirchmair R, Patsch JR. Flow-mediated vasodilation of the femoral and brachial artery induced by exercise in healthy nonsmoking and smoking men. J Am Coll Cardiol 2001;38(5):1313-1319.

41. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979;241:2035-2038.

42. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339(4):229-234.

43. Pyorala K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabete Metab Rev 1987;3:463-524.

44. Reaven GM, Laws A. Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease. Diabetologia 1994;37:948-952.

45. Reiber GE, Pecoraro RE, Koepsell TD. Risk factors for amputation in patientswith diabetes mellitus. A case-control study. Ann Intern Med 1992;117:97-105.

46. Morris AD, McAlpine R, Steinke D, et al. Diabetes and lower-limb amputations in the community. A retrospective cohort study. DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland/Medicines Monitoring Unit. Diabetes Care 1998;21: 738-743.

47. Ebskov B, Josephsen P. Incidence of reamputation and death after gangrene of the lower extremity. Prosthet Orthot Int 1980;4(2):77-80.

48. Lee JS, Lu M, Lee VS, Russell D, Bahr C, Lee ET. Lower-extremity amputation. Incidence, risk factors, and mortality in the Oklahoma Indian Diabetes Study. Diabetes 1993;42(6):876-882.

49. Van Damme H. Crural or pedal artery revascularisation for limb salvage: is it justified? Acta Chir Belg 2004;104:148-157.

50. Weitz JI, Byrne J, Clagett GP, et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 1996;94:3026-3049.

51. Holstein P, Ellitsgaard N, Olsen BB, Ellitsgaard V. Decreasing incidence of major amputations in people with diabetes. Diabetologia 2000;43:844-847.

52. American Diabetes Association. Peripheral Arterial Disease in people with diabetes. Diabetes Care 2003;26:3333-3341.

53. Pomposelli FB, Jr, Kansal N, Hamdan AD, et al. A decade of experience with dorsalis pedis artery bypass: Analysis of outcome in more than 1000 cases. J Vasc Surg 2003;37: 307-315.

54. Kumpe DA, Rutherford RB. Percutaneous transluminal angioplasty for lower extremity ischemia, in Vascular Surgery (Rutherford RB, ed.), 3rd ed., WB Saunders, Philadelphia PA, 1992, pp. 759-761.

55. London NJ, Varty K, Sayers RD, Thompson MM, Bell PR, Bolia A. Percutaneous transluminal angioplasty for lower-limb critical ischaemia. Br J Surg 1995;82(9):1232-1235.

56. Faglia E, Dalla Paola L, Clerici G, et al. Peripheral angioplasty as the first-choice revas-cularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur J Vasc Endovasc Surg 2005;29(6):620-627.

57. Tesfaye S, Chaturvedi N, Eaton SE, et al. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005;352(4):341-350.

58. Pryce TD. On diabetic neuritis, with a clinical and pathological description of three cases of diabetic pseudo-tabes. Brain 1893;16:416.

59. Nukada H, van Rij AM, Packer SG, McMorran PD. Pathology of acute and chronic ischaemic neuropathy in atherosclerotic peripheral vascular disease. Brain 1996;119: 1449-1460.

60. McKenzie D, Nukada H, van Rij AM, McMorran PD. Endoneurial microvascular abnormalities of sural nerve in non-diabetic chronic atherosclerotic occlusive disease. J Neurol Sci 1999;162:84-88.

61. Young MJ, Veves A, Walker MG, Boulton AJ. Correlations between nerve function and tissue oxygenation in diabetic patients: further clues to the aetiology of diabetic neuropathy? Diabetologia 1992;35:1146-1150.

62. Veves A, Donaghue VM, Sarnow MR, Giurini JM, Campbell DR, LoGerfo FW. The impact of reversal of hypoxia by revascularization on the peripheral nerve function of diabetic patients. Diabetologia 1996;39:344-348.

63. Akbari CM, Gibbons GW, Habershaw GM, LoGerfo FW, Veves A. The effect of arterial reconstruction on the natural history of diabetic neuropathy. Arch-Surg 1997;132:148-152.

64. Malik RA, Williamson S, Abbott CA, et al. Effect of angiotensin-converting enzyme (ACE) inhibitor trandalopril on human diabetic neuropathy: randomised double-blind controlled trial. Lancet 1998;352:1978-1981.

65. Estacio RO, Jeffers BW, Gifford N, Schrier RW. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care 2000;23:B54-B64.

Blood Pressure Health

Blood Pressure Health

Your heart pumps blood throughout your body using a network of tubing called arteries and capillaries which return the blood back to your heart via your veins. Blood pressure is the force of the blood pushing against the walls of your arteries as your heart beats.Learn more...

Get My Free Ebook


Post a comment